These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38385116)

  • 1. Occult urothelial carcinoma with mediastinal metastasis: A case report.
    Zheng J; Peng X; Li X; Chen Y; Li X; Fu L; Li A; Lu Z
    Oncol Lett; 2024 Apr; 27(4):148. PubMed ID: 38385116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated cerebellar metastasis from urothelial carcinoma: A case report of a rare phenomenon.
    Verheijen EJA; Taal W; Tewari RDSN; Giessen MCA; Roshani H
    Brain Spine; 2023; 3():102716. PubMed ID: 38105804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Three cases of occult thyroid cancer with mediastinal lymph node metastasis manifesting as a mediastinal cyst].
    Okumura M; Yasumitsu T; Kotake Y; Ohta M; Ohshima S; Miyauchi A
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Nov; 38(11):2307-13. PubMed ID: 2280107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular cutaneous metastasis of the leg in advanced urothelial bladder carcinoma: a case report and systematic literature review.
    Izzo P; Izzo L; Lai S; D'Onghia G; Giancontieri P; Gabriele R; Polistena A; Sibio S; Costanzo ML; De Intinis C; Izzo S
    Front Oncol; 2023; 13():1216725. PubMed ID: 37675233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases.
    Bontoux C; Rialland T; Cussenot O; Compérat E
    Virchows Arch; 2021 Apr; 478(4):637-645. PubMed ID: 33128085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urothelial Carcinoma of the Bladder With Primary Metastasis to the Brain: A Case Report and Literature Review.
    Sankhyan M; Anderson EM; Urquiaga JF; Hockman JT; Aggarwal R; El Tecle NE; Mercier PJ
    Cureus; 2022 Aug; 14(8):e27587. PubMed ID: 36059295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinal hemangioma mimicking an invasive tumor growth: A case report.
    Yobita S; Iizuka S; Otsuki Y; Nakamura T
    Int J Surg Case Rep; 2021 Mar; 80():105674. PubMed ID: 33662913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological Parameters predicting Occult Nodal Metastases in Tongue Carcinoma Cases: An Indian Perspective.
    Jacob TE; Malathi N; Rajan ST; Augustine D; Manish N; Patil S
    J Contemp Dent Pract; 2016 Jan; 17(1):70-7. PubMed ID: 27084866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas.
    Zhao L; Antic T; Witten D; Paner GP; Taxy JB; Husain A; Gwin K; Mirza MK; Lingen MW; Tretiakova MS
    Am J Surg Pathol; 2013 Dec; 37(12):1876-81. PubMed ID: 24121175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologically confirmed distant metastatic urothelial carcinoma from the urinary bladder: a retrospective review of one institution's 20-year experience.
    Yoo Y; Lee J; Park HS; Cho MS; Sung SH; Park S; Choi E
    J Pathol Transl Med; 2021 Mar; 55(2):94-101. PubMed ID: 33260285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
    Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
    Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult Metastases in Pelvic Lymphadenectomy Specimens From Patients With Urothelial Carcinoma of the Bladder.
    Gordetsky J; Gibson B; Stevens TM; Ellenburg JL; Grizzle W; Rais-Bahrami S
    Urology; 2016 Aug; 94():161-6. PubMed ID: 27184604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
    Kanzaki R; Higashiyama M; Fujiwara A; Tokunaga T; Maeda J; Okami J; Kozuka T; Hosoki T; Hasegawa Y; Takami M; Tomita Y; Kodama K
    Lung Cancer; 2011 Mar; 71(3):333-7. PubMed ID: 20619479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma.
    Tripathi N; Jo Y; Tripathi A; Sayegh N; Li H; Nussenzveig R; Haaland B; Thomas VM; Gupta S; Maughan BL; Swami U; Pal SK; Grivas P; Agarwal N; Sirohi D
    Urol Oncol; 2022 Nov; 40(11):493.e1-493.e7. PubMed ID: 35918248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.
    Lee PC; Port JL; Korst RJ; Liss Y; Meherally DN; Altorki NK
    Ann Thorac Surg; 2007 Jul; 84(1):177-81. PubMed ID: 17588407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
    Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
    Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
    Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
    Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.